HIF1A and type 2 diabetes mellitus: HIF-1α, a key regulator of cellular response to hypoxia, is emerging as a promising biomarker in EC, especially in patients with T2DM implicating both diseases, suggesting a potential molecular relationship that warrants further investigation.